(S (NP (NN Machine) (NN learning)) (VP (VBZ has) (VP (VBN become) (NP (NP (UCP (ADJP (JJ ubiquitous)) (CC and) (NP (NP (DT a) (JJ key) (NN technology)) (PP (IN on) (NP (NN mining))))) (NML (JJ electronic) (NN health)) (NNS records)) (-LRB- -LRB-) (NP (NNS EHRs)) (-RRB- -RRB-)) (PP (IN for) (S (VP (VBG facilitating) (NP (JJ clinical) (NN research) (CC and) (NN practice))))))) (. .))
(S (NP (NP (JJ Unsupervised) (NN machine) (NN learning)) (, ,) (SBAR (IN as) (S (VP (VBN opposed) (PP (IN to) (NP (JJ supervised) (NN learning)))))) (, ,)) (VP (VBZ has) (VP (VBN shown) (NP (NN promise)) (PP (IN in) (S (VP (VBG identifying) (NP (JJ novel) (NNS patterns) (CC and) (NNS relations)) (PP (IN from) (NP (NNS EHRs))) (PP (IN without) (S (VP (VBG using) (NP (JJ human) (VBN created) (NNS labels)))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP investigate) (NP (NP (DT the) (NN application)) (PP (IN of) (NP (JJ unsupervised) (NML (NN machine) (NN learning)) (NNS models)))) (PP (IN in) (S (VP (VBG discovering) (NP (NP (NN latent) (NN disease) (NNS clusters)) (CC and) (NP (JJ patient) (NNS subgroups))) (PP (VBN based) (PP (IN on) (NP (NNS EHRs)))))))) (. .))
(S (S (NP (PRP We)) (VP (VP (VBD utilized) (NP (NP (NP (NNP Latent) (NNP Dirichlet) (NNP Allocation)) (-LRB- -LRB-) (NP (NNP LDA)) (-RRB- -RRB-)) (, ,) (NP (DT a) (ADJP (JJ generative) (JJ probabilistic)) (NN model)))) (, ,) (CC and) (VP (VBD proposed) (NP (NP (DT a) (JJ novel) (NN model)) (VP (VBN named) (NP (NP (NP (NNP Poisson) (NNP Dirichlet) (NNP Model)) (-LRB- -LRB-) (NP (NNP PDM)) (-RRB- -RRB-)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ extends) (NP (DT the) (NN LDA) (NN approach)) (S (VP (VBG using) (NP (DT a) (NNP Poisson) (NN distribution)) (PP (IN to) (NP (NP (NN model) (NNS patients) (POS ')) (NN disease) (NNS diagnoses)))))))))))))) (CC and) (S (VP (TO to) (VP (VB alleviate) (NP (NML (NN age) (CC and) (NN sex)) (NNS factors)) (PP (IN by) (S (VP (VBG considering) (NP (NP (DT both) (VBN observed)) (CC and) (NP (VBN expected) (NNS observations))))))))) (. .))
(S (PP (IN In) (NP (DT the) (JJ empirical) (NNS experiments))) (, ,) (NP (PRP we)) (VP (VBD evaluated) (NP (NNP LDA) (CC and) (NNP PDM)) (PP (IN on) (NP (CD three) (JJ patient) (NNS cohorts))) (PP (IN with) (NP (NP (NNP EHR) (NNS data)) (VP (VBN retrieved) (PP (IN from) (NP (DT the) (NNP Rochester) (NNP Epidemiology) (NNP Project))) (PRN (-LRB- -LRB-) (NP (NN REP)) (-RRB- -RRB-))))) (, ,) (PP (IN for) (NP (NP (DT the) (NN discovery)) (PP (IN of) (NP (NP (JJ latent) (NN disease) (NNS clusters)) (CC and) (NP (JJ patient) (NNS subgroups))))))) (. .))
(S (NP (PRP We)) (VP (VBD compared) (NP (NP (DT the) (NN effectiveness)) (PP (IN of) (NP (NN LDA) (CC and) (NN PDM)))) (PP (IN in) (S (VP (VBG identifying) (NP (NN latent) (NN disease) (NNS clusters)) (PP (IN through) (NP (NP (DT the) (NN visualization)) (PP (IN of) (NP (NP (NN disease) (NNS representations)) (VP (VBN learned) (PP (IN by) (NP (CD two) (NNS approaches)))))))))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBD tested) (NP (NP (DT the) (NN performance)) (PP (IN of) (NP (NN LDA) (CC and) (NN PDM)))) (PP (IN in) (S (VP (VBG differentiating) (NP (NN patient) (NNS subgroups)) (PP (IN through) (NP (NP (NN survival) (NN analysis)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (JJ statistical) (NN analysis)))))))) (. .))
(S (S (NP (DT The) (JJ experimental) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (NP (DT the) (VBN proposed) (NN PDM)) (VP (MD could) (ADVP (RB effectively)) (VP (VB identify) (NP (JJ distinguished) (NN disease) (NNS clusters)) (PP (IN by) (S (VP (VBG alleviating) (NP (NP (DT the) (NN impact)) (PP (IN of) (NP (NN age) (CC and) (NN sex))))))))))))) (, ,) (CC and) (S (NP (DT that) (NN LDA)) (VP (MD could) (VP (VB stratify) (NP (NNS patients)) (PP (IN into) (NP (NP (JJR more) (JJ differentiable) (NNS subgroups)) (PP (IN than) (NP (NN PDM))))) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NN p) (HYPH -) (NNS values)))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NNS subgroups)) (VP (VBN discovered) (PP (IN by) (NP (NNP PDM))))) (VP (MD might) (VP (VB imply) (NP (NP (DT the) (VBG underlying) (NNS patterns)) (PP (IN of) (NP (NP (NNS diseases)) (PP (IN of) (NP (NP (JJR greater) (NN interest)) (PP (IN in) (NP (NN epidemiology) (NN research)))))))) (PP (IN due) (PP (IN to) (NP (NP (DT the) (NN alleviation)) (PP (IN of) (NP (NN age) (CC and) (NN sex)))))))) (. .))
(S (NP (NP (DT Both) (JJ unsupervised) (NN machine)) (VP (VBG learning) (NP (NNS approaches)))) (VP (MD could) (VP (VB be) (ADJP (VBN leveraged) (S (VP (TO to) (VP (VB discover) (NP (JJ patient) (NNS subgroups)) (S (VP (VBG using) (NP (NNS EHRs)) (NAC (CC but) (PP (IN with) (NP (JJ different) (NNS foci)))))))))))) (. .))
